Revvity Gross Profit 2010-2024 | RVTY

Revvity annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Revvity gross profit for the quarter ending September 30, 2024 was $0.385B, a 3.3% increase year-over-year.
  • Revvity gross profit for the twelve months ending September 30, 2024 was $1.509B, a 5.26% decline year-over-year.
  • Revvity annual gross profit for 2023 was $1.54B, a 22.62% decline from 2022.
  • Revvity annual gross profit for 2022 was $1.99B, a 18.25% decline from 2021.
  • Revvity annual gross profit for 2021 was $2.434B, a 40.68% increase from 2020.
Revvity Annual Gross Profit
(Millions of US $)
2023 $1,540
2022 $1,990
2021 $2,434
2020 $1,730
2019 $1,396
2018 $1,341
2017 $1,074
2016 $1,014
2015 $964
2014 $935
2013 $976
2012 $962
2011 $848
2010 $759
2009 $701
Revvity Quarterly Gross Profit
(Millions of US $)
2024-09-30 $385
2024-06-30 $386
2024-03-31 $355
2023-12-31 $383
2023-09-30 $373
2023-06-30 $402
2023-03-31 $381
2022-12-31 $436
2022-09-30 $407
2022-06-30 $552
2022-03-31 $595
2021-12-31 $441
2021-09-30 $523
2021-06-30 $685
2021-03-31 $785
2020-12-31 $447
2020-09-30 $527
2020-06-30 $447
2020-03-31 $308
2019-12-31 $398
2019-09-30 $342
2019-06-30 $348
2019-03-31 $308
2018-12-31 $376
2018-09-30 $332
2018-06-30 $340
2018-03-31 $292
2017-12-31 $307
2017-09-30 $269
2017-06-30 $258
2017-03-31 $240
2016-12-31 $277
2016-09-30 $249
2016-06-30 $254
2016-03-31 $235
2015-12-31 $222
2015-09-30 $255
2015-06-30 $253
2015-03-31 $235
2014-12-31 $208
2014-09-30 $243
2014-06-30 $248
2014-03-31 $236
2013-12-31 $276
2013-09-30 $233
2013-06-30 $242
2013-03-31 $225
2012-12-31 $260
2012-09-30 $231
2012-06-30 $239
2012-03-31 $232
2011-12-31 $239
2011-09-30 $199
2011-06-30 $209
2011-03-31 $200
2010-12-31 $208
2010-09-30 $186
2010-06-30 $189
2010-03-31 $175
2009-12-31 $156
2009-09-30 $169
2009-06-30 $188
2009-03-31 $189
Sector Industry Market Cap Revenue
Medical Medical Services $13.376B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00